icad Inc (ICAD)

3.64
0.01 0.28
NASDAQ : Technology
Prev Close 3.63
Open 3.64
Day Low/High 3.50 / 3.78
52 Wk Low/High 2.95 / 6.23
Volume 83.33K
Avg Volume 28.20K
Exchange NASDAQ
Shares Outstanding 16.59M
Market Cap 61.07M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ICAD Announces Positive Study Results Comparing Use Of Company's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® To Mohs Surgery In Treatment Of Early-stage Non-melanoma Skin Cancer

ICAD Announces Positive Study Results Comparing Use Of Company's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® To Mohs Surgery In Treatment Of Early-stage Non-melanoma Skin Cancer

Results of breakthrough study published in peer-reviewed Journal of Contemporary Brachytherapy showed no statistically significant difference in recurrence of cancer at mean follow-up of 3.4 years

Carolina Breast Imaging Specialists Adopts ICAD's Advanced Artificial Intelligence Technology For Digital Breast 3D Tomosynthesis

iCAD's revolutionary PowerLook® Tomo Detection deep learning solution helps radiologists identify breast cancer more efficiently

First-Ever European Analysis Of Electronic Brachytherapy Using The Xoft System For Endometrial And Cervical Cancer Treatment To Be Presented At European Society For Radiotherapy & Oncology Meeting

Preliminary results show targeted treatment offers low toxicity for patients with endometrial or cervical cancer

ICAD Announces First Early-Stage Breast Cancer Patient Treated With Intraoperative Radiation Therapy Using The Xoft System At Monash Cancer Centre, A Partnership Between Peter MacCallum Cancer Centre And Monash Health In Australia

First installation of advanced, multi-platform Xoft System in Australia increases global access to versatile, clinically proven technology

ICAD To Showcase Breakthrough Early-Stage Breast Cancer Treatment Utilizing The Xoft System At American Society Of Breast Surgeons (ASBrS) Annual Meeting

Company to host in-booth presentations by clinical experts to review recent experience with one-day intraoperative radiation therapy

A Portfolio of Fixed Income, Pass Throughs and Small Caps

A Portfolio of Fixed Income, Pass Throughs and Small Caps

This portfolio is designed to produce a blended yield of 6% to 8%.

Researchers To Present Updated Clinical Data On Intraoperative Radiation Therapy Using The Xoft System At American Brachytherapy Society (ABS) Annual Meeting

Company to showcase breakthrough, multi-platform technology for the treatment of early-stage breast cancer, non-melanoma skin cancer and gynecological cancers at booth #T1

ICAD To Showcase PowerLook Tomo Detection Technology At SBI/ACR Breast Imaging Symposium

Latest digital breast 3D tomosynthesis solution builds on deep learning technology to improve radiologist workflow and significantly reduce reading time

ICAD Receives FDA Approval For PowerLook Tomo Detection

First to market with innovative digital breast 3D tomosynthesis cancer detection and workflow solution, built on deep learning technology that improves efficiency and reduces reading time for radiologists

ICAD Announces More Than 3,000 Early-Stage Breast Cancer Patients Treated With Intraoperative Radiation Therapy Using The Xoft System

Company to showcase breakthrough one-day breast cancer treatment technology and host in-booth clinician expert at Physicians' Education Resource® 34th Annual Miami Breast Cancer Conference

ICAD Showcases Targeted, Non-Surgical Non-Melanoma Skin Cancer Treatment At AAD 2017

Company to highlight breakthrough Xoft System offering excellent clinical results and host in-booth Lunch and Learn sessions featuring clinical experts to discuss strategies and outcomes in patient care

ICAD Announces Management Transition

ICAD Announces Management Transition